Chaparral Monograph

Bibliography

• Rillema J A. Effect of NDGA, a lipoxygenase inhibitor, on prolactin actions in mouse mammary gland explants. Prostaglandins Leukot Med 1984; 16(1)89–94
   PubMedGoogle Scholar
• Obermeyer W R, Musser S M, Betz J M, et al. Chemical studies of phyto-estrogens and related compounds in dietary supplements: flax and chaparral. Proc Soc Exp Biol Med 1995; 208(1)6–12
   PubMed Web of Science ®Google Scholar
• Goodman T, Grice H C, Becking G C, et al. A cystic nephropathy induced by nordihydroguaiaretic acid in the rat. Light and electron microscopic investigations. Lab Invest 1970; 23(1)93–107
   PubMed Web of Science ®Google Scholar
• Cranston E M, Jensen M J, Moren M J, et al. The acute and chronic toxicity of nordihydroguaiaretic acid. Fed Proc 1947; 6: 318–319
   Google Scholar
• Leonforte J F. Contact dermatitis from Larrea (creosote bush). J Am Acad Dermatol 1986; 14(2 Pt 1)202–207
   PubMed Web of Science ®Google Scholar
• Shasky D R. Contact dermatitis from Larrea tridentata (creosote bush). J Am Acad Dermatol 1986; 15((2 Pt 1))302
   PubMed Web of Science ®Google Scholar
• Smart C R, Hogle H H, Vogel H, et al. Clinical experience with nordihydro-guaiaretic acid—“chaparrel tea” in the treatment of cancer. Rocky Mt Med J 1970; 67(11)39–43
   Google Scholar
• Sheikh N M, Philen R M, Love L A. Chaparral-associated hepatotoxicity. Arch Intern Med 1997; 157(8)913–919
   PubMed Web of Science ®Google Scholar
• Smith A Y, Feddersen R M, Gardner K D, Jr., et al. Cystic renal cell carcinoma and acquired renal cystic disease associated with consumption of chaparral tea: a case report. J Urol 1994; 152((6 Pt 1))2089–2091
   PubMed Web of Science ®Google Scholar
• Evan A P, Gardner K D, Jr. Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int 1979; 15(1)7–19
   PubMed Web of Science ®Google Scholar
• Alderman S, Kailas S, Goldfarb S, et al. Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy. J Clin Gastroenterol 1994; 19(3)242–247
   PubMed Web of Science ®Google Scholar
• Anonymous. Chaparral-induced toxic hepatitis-California and Texas, 1992. MMWR Morb Mortal Wkly Rep 1992; 41(43)812–814
   PubMedGoogle Scholar
• Batchelor W B, Heathcote J, Wanless I R. Chaparral-induced hepatic injury. Am J Gastroenterol 1995; 90(5)831–833
   PubMed Web of Science ®Google Scholar
• Clark F. Chaparral-induced toxic hepatitis: California and Texas, 1992. MMWR Morb Mortal Wkly Rep 1992; 41: 812–814
   PubMedGoogle Scholar
• Gordon D W, Rosenthal G, Hart J, et al. Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA 1995; 273(6)489–490
   PubMed Web of Science ®Google Scholar
• Katz M, Saibil F. Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J Clin Gastroenterol 1990; 12(2)203–206
   PubMed Web of Science ®Google Scholar
• Smith B C, Desmond P V. Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust N Z J Med 1993; 23((5))526
   PubMedGoogle Scholar
• Gimeno M F, Shattner M A, Borda E, et al. Lipoxygenase inhibitors alter aggregation and adhesiveness of human blood platelets from aspirin-treated patients. Prost-aglandins Leukot Med 1983; 11(1)109–119
   PubMed Web of Science ®Google Scholar
• Luo J, Chuang T, Cheung J, et al. Masoprocol (nordihydroguaiaretic acid): a new antihyperglycemic agent isolated from the creosote bush (Larrea tridentata). Eur J Pharmacol 1998; 346(1)77–79
   PubMed Web of Science ®Google Scholar
• Agarwal R, Wang Z Y, Bik D P, et al. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes. Drug Metab Dispos. 1991; 19(3)620–624
   PubMed Web of Science ®Google Scholar
• Nakadate T, Yamamoto S, Aizu E, et al. Inhibition of 12-O-tetradecanoyl-phorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipo-xygenase inhibitors. Jpn J Pharmacol 1985; 38(2)161–168
   PubMedGoogle Scholar
• Salari H, Braquet P, Borgeat P. Comparative effects of indomethacin, acetyl-enic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Med 1984; 13((1))53–60
   PubMedGoogle Scholar
• Grice H C, Becking G, Goodman T. Toxic properties of nordihydroguaiaretic acid. Food Cosmet Toxicol 1968; 6(2)155–161
   PubMedGoogle Scholar
• Smart C R, Hogle H H, Robins R K, et al. An interesting observation on nordi-hydroguaiaretic acid (NSC-4291; NDGA) and a patient with malignant melanoma-a preliminary report. Cancer Chemother Rep 1969; 53(2)147–151
   PubMedGoogle Scholar
• Birkenfeld S, Zaltsman Y A, Krispin M, et al. Antitumor effects of inhibitors of arachidonic acid cascade on experimentally induced intestinal tumors. Dis Colon Rectum 1987; 30(1)43–46
   PubMed Web of Science ®Google Scholar